Paperpal Prime Logo

Current Drug Targets : Impact Factor & More

eISSN: 1873-5592pISSN: 1389-4501

Key Metrics

CiteScore
6.1
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Drug Targets

Current Drug Targets Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Drug Targets ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Drug Targets

Extracellular Vesicles from Mesenchymal Stem Cells Alleviate Spinal Cord Injury via the miR-486-5p/PTEN/PI3K/AKT Pathway.
  • 30 Jun 2026
  • Current drug targets
Mechanistic Insights into the Inhibition of Plasmodium falciparum DNA Gyrase A by Withanolide Derivatives through Integrated Computational Analysis.
  • 23 Jun 2026
  • Current drug targets
Epitranscriptomics in Breast Cancer: The Unveiled Role of RNA Modifications.
  • 19 Jun 2026
  • Current drug targets
Neuroinflammation in Alzheimer's Disease: New Approaches.
  • 11 Jun 2026
  • Current drug targets
Multi-target Agents in Complex Diseases: From Design Principles to Therapeutic Applications.
  • 11 Jun 2026
  • Current drug targets
FXYD3: A Key Regulator of Ion Homeostasis and Redox Balance in Cancer Biology.
  • 11 Jun 2026
  • Current drug targets
Extracellular Vesicles from Mesenchymal Stem Cells Alleviate Spinal Cord Injury via the miR-486-5p/PTEN/PI3K/AKT Pathway.
  • 30 Jun 2026
  • Current drug targets
Mechanistic Insights into the Inhibition of Plasmodium falciparum DNA Gyrase A by Withanolide Derivatives through Integrated Computational Analysis.
  • 23 Jun 2026
  • Current drug targets
Epitranscriptomics in Breast Cancer: The Unveiled Role of RNA Modifications.
  • 19 Jun 2026
  • Current drug targets
Neuroinflammation in Alzheimer's Disease: New Approaches.
  • 11 Jun 2026
  • Current drug targets
Multi-target Agents in Complex Diseases: From Design Principles to Therapeutic Applications.
  • 11 Jun 2026
  • Current drug targets
FXYD3: A Key Regulator of Ion Homeostasis and Redox Balance in Cancer Biology.
  • 11 Jun 2026
  • Current drug targets

FAQs on Current Drug Targets